IART
INTEGRA LIFESCIENCES HOLDINGS CORP
-0.29 (-1.81%)15.77USD273K成交股數1.2B市值–本益比(近四季)0.7股價營收比+0.8%營收年增(近四季)2026-10-29下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 419M+9% | 392M-11% | 402M+6% | 416M-1% | 383M+4% | 443M+16% | 381M-0% | 418M+10% | 369M | 382M | 381M | 381M |
| 營業成本 | 199M | 175M | 195M | 206M | 188M | 194M | 181M | 192M | 162M | 164M | 174M | 148M |
| 毛利 | 220M+13% | 217M-13% | 207M+3% | 209M-7% | 194M-6% | 249M+14% | 200M-3% | 226M-3% | 207M | 218M | 207M | 233M |
| 毛利率 | 52.5% | 55.4% | 51.5% | 50.4% | 50.8% | 56.3% | 52.6% | 54.0% | 56.1% | 57.1% | 54.3% | 61.1% |
| 研發費用 | 24.3M | 23.5M | 22.5M | 27.0M | 24.7M | 31.2M | 27.4M | 29.8M | 27.0M | 26.6M | 26.6M | 26.7M |
| 銷售管理費用 | 172M | 178M | 169M | 180M | 181M | 179M | 177M | 195M | 166M | 162M | 165M | 167M |
| 營業利益 | 19.3M-224% | 11.5M-68% | 11.8M-244% | −513M+16826% | −15.5M-491% | 35.6M+34% | −8.2M-165% | −3.0M-108% | 4.0M | 26.6M | 12.5M | 36.4M |
| 營業利益率 | 4.6% | 2.9% | 2.9% | -123.4% | -4.0% | 8.0% | -2.1% | -0.7% | 1.1% | 7.0% | 3.3% | 9.6% |
| 稅後淨利 | 4.5M-118% | −4.6M-124% | −5.4M-49% | −484M+3803% | −25.3M+671% | 19.5M-0% | −10.7M-356% | −12.4M-151% | −3.3M | 19.5M | 4.2M | 24.2M |
| 淨利率 | 1.1% | -1.2% | -1.3% | -116.5% | -6.6% | 4.4% | -2.8% | -3.0% | -0.9% | 5.1% | 1.1% | 6.4% |
| 稀釋 EPS | 0.06-118% | -0.06-124% | -0.07-50% | -6.31+3844% | -0.33+725% | 0.25+4% | -0.14-380% | -0.16-155% | -0.04 | 0.24 | 0.05 | 0.29 |
| 稀釋股數 | 78.2M | 77.0M | 76.8M | 76.7M | 76.5M | 77.0M | 76.4M | 77.4M | 77.7M | 79.8M | 81.2M | 82.3M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 214M | 237M | 232M | 218M | 239M | 246M | 215M | 215M | 592M | 274M | 309M | 307M |
| 應收帳款 | 267M | 264M | 262M | 285M | 252M | 272M | 248M | 271M | 241M | 256M | 259M | 254M |
| 存貨 | 492M | 495M | 489M | 465M | 445M | 429M | 437M | 422M | 403M | 366M | 354M | 351M |
| 總資產 | 3.6B | 3.6B | 3.6B | 3.7B | 4.1B | 4.0B | 4.1B | 4.1B | 4.1B | 3.7B | 3.8B | 3.7B |
| 有息負債 | 707M | 717M | 736M | 746M | 756M | 760M | 765M | 770M | 775M | 775M | 775M | 775M |
| 總負債 | 2.5B | 2.5B | 2.6B | 2.6B | 2.5B | 2.5B | 2.5B | 2.5B | 2.5B | 2.2B | 2.1B | 2.1B |
| 股東權益 | 1.0B | 1.0B | 1.0B | 1.0B | 1.5B | 1.5B | 1.5B | 1.5B | 1.6B | 1.6B | 1.7B | 1.7B |
| 負債比 | 70.7% | 70.9% | 71.5% | 71.7% | 62.4% | 61.7% | 62.6% | 62.3% | 60.8% | 57.8% | 55.4% | 55.2% |
| 淨現金(現金 − 有息負債) | −493M | −480M | −504M | −528M | −517M | −514M | −550M | −555M | −183M | −501M | −466M | −468M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 9.8M | – | – | −11.3M-171% | – | – | – | 15.8M | – | – | 26.2M |
| 資本支出 | – | 14.8M | – | – | 28.9M | – | – | – | 15.5M | – | – | 13.7M |
| 自由現金流 | – | −5.0M | – | – | −40.2M-13907% | – | – | – | 291K | – | – | 12.5M |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | 0.00 | – | – | 150M |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -1.3% | – | – | -10.5% | – | – | – | 0.1% | – | – | 3.3% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 1.6B
| Codman Specialty Surgical | 1.2B | 73.4% | +5.0% |
|---|---|---|---|
| Tissue Technologies | 435M | 26.6% | -6.9% |
地區2025 年度 · 1.6B
| 美國 | 1.2B | 73.7% | +1.0% |
|---|---|---|---|
| 亞太 | 189M | 11.6% | +7.2% |
| 歐洲 | 163M | 9.9% | +2.6% |
| Rest Of The World | 78.6M | 4.8% | -5.0% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 1.6B | +1.5% | −517M | -31.6% | -6.74 | −31.1M |
| FY2024 | 1.6B | +4.5% | −6.9M | -0.4% | -0.09 | 25.0M |
| FY2023 | 1.5B | -1.0% | 67.7M | 4.4% | 0.84 | 73.1M |
| FY2022 | 1.6B | +1.0% | 181M | 11.6% | 2.16 | 222M |
| FY2021 | 1.5B | +12.4% | 169M | 11.0% | 1.98 | 264M |
| FY2020 | 1.4B | -9.6% | 134M | 9.8% | 1.57 | 165M |
| FY2019 | 1.5B | +3.1% | 50.2M | 3.3% | 0.58 | 162M |
| FY2018 | 1.5B | – | 60.8M | 4.1% | 0.72 | 122M |